Mont-Saint-Guibert, Belgium - Celyad (formerly known as Cardio3 BioSciences, Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell therapies, today announced that it will report its financial results for the six months ended 30 June, 2015 on Tuesday 25 August, 2015 at 7:00am CET.

A conference all will be held on Tuesday 25 August at 2:00pm CET / 8:00am EDT to review the financial results. Christian Homsy, Chief Executive Officer, and Patrick Jeanmart, Chief Financial Officer, will deliver a brief presentation followed by a Q&A session.

Participants are asked to call the assigned number approximately five minutes before the conference call begins.

The call can be accessed by dialing the numbers below and quoting conference ID number 11186221.

Participant International Dial-In: +44 (0) 1452 555566
Belgium: 0800 40 864
France: 0805 632 056
United States: 1 866 966 9439

Download press release(s)

Communiqué de presse

314.46 Ko

Persbericht

273.21 Ko

Press release

306.67 Ko

Celyad reports First Half 2015 financial results and operational progress

Next News

Celyad reports First Half 2015 financial results and operational progress